ManageEngine RecoveryManager Plus
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
A side-by-side editorial comparison of pharmaverseadam and silx — release velocity, themes, recent moves, and the top alternatives to consider.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
silx settles into maintenance a release after its PySide6 migration
silx is in the quiet phase after a generational release. 3.1.1 is a single fix to FitWidget loading a fit function from file. The release before it, 3.1.0, was the first real feature work since the migration - asinh axis scaling, twilight colormaps, and dark-theme icons - and 3.0.1 was similarly small. The 3.0.0 cut that reset the Qt binding and Python floor still defines what the line is doing.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
silx is in the quiet phase after a generational release. 3.1.1 is a single fix to FitWidget loading a fit function from file. The release before it, 3.1.0, was the first real feature work since the migration - asinh axis scaling, twilight colormaps, and dark-theme icons - and 3.0.1 was similarly small. The 3.0.0 cut that reset the Qt binding and Python floor still defines what the line is doing.
The cadence has slowed markedly since April, and the content has shifted from structural change to plotting and colormap refinement. That is the expected shape after a binding migration: downstream beamline code needs a stable target, so the project trades feature velocity for a quiet surface. The gap between 3.0.1 in May and 3.1.0 in August is the clearest signal of the deliberate slowdown.
Expect further point releases servicing the plotting and fitting widgets rather than another structural change, with feature work continuing to arrive in the 3.1.x minors rather than patches.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either pharmaverseadam or silx.
RecoveryManager Plus keeps widening its backup coverage across the Microsoft identity estate.
Omni ships weekly, and almost every week the headline item is an AI feature.
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
See all pharmaverseadam alternatives → · See all silx alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. silx is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. silx is currently shipping more aggressively (velocity 5.0 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.
Top silx alternatives in Analytics are ranked by recent ship velocity. Browse the "silx alternatives" section above for the current picks, or visit /alternatives/silx for the full list with editorial commentary on each.